Book Value per Share: Passage Bio (PASG)
Passage Bio, Inc. (PASG) expenditures are driven by the development of AAV vectors for the treatment of brain pathologies. The book value per share displayed on the GURU.Markets portal captures asset dynamics, where 1.38 reflects the latest metric value. Passage Bio, Inc. (PASG) aims for the complete cure of rare genetic CNS disorders, although the business is currently in the pre-commercial stage with rising clinical trial costs.
Passage Bio Inc. - analytical breakdowns and key metrics (PASG)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:passagebio.com, PASG
For an investor in Passage Bio, Inc. (PASG), the fundamental valuation of assets is critical when analyzing the cost of gene therapy development. This metric reflects the volume of equity minus liabilities, and the book value per share allows for an assessment of management's financial stability as they push the portfolio through clinical filters, determining the real safety cushion against market optimism.
Competitor analysis for Passage Bio, Inc.
Net Assets per Single Share BIIB (Biogen Corp)|NBIX - Net Assets per Share|Book Value per Share RGC (Regencell Bioscience)|AXSM (axsome.com) - Book Value of One Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines PRAX|Share Book Value anavex.com|Book Value per Share CBLL|Book Value per Share PRTA (Prothena Corporation)|Net Assets per Single Share ALEC|Annexon Biosciences Inc. - Net Assets per Share|Net Assets per Single Share OMER (Omeros Corp.)|NGNE - Net Assets per Share|ACIU: Book Value per Share|Voyager Therapeutics Inc (VYGR) - Book Value per Share|Neumora Therapeutics Inc - Book Value per Share|Book Value of One Share Scilex Holding Company, Inc.|Tevogen Bio Holdings - Book Value per Share|Net Asset Value per Share alphacognition.com ACOG|Accounting Value per Share Cognition Therapeutics|Accounting Value of a Share Inhibikase Therapeutics Inc IKT|SAVA - Book Value per Share|ASRT - Net Assets per Single Share|coyatherapeutics.com - Book Value per Share|VTGN (Vistagen) - Net Assets per Share|Net Assets per Single Share OVID (Ovid Therapeutics Inc)|Net Asset Value per Share Acumen Pharmaceuticals Inc. (ABOS)|CervoMed Inc (CRVO) - Accounting Value per Share|Accounting Value of a Share alteritytherapeutics.com (ATHE)|Book Value per Share CLNN|PepGen Inc - Net Assets per Share|Jupiter Neurosciences Inc (JUNS) - Net Assets per Single Share|RLMD - Equity per Share|ANVS (Annovis Bio Corp) - Book Value per Share|Accounting Value per Share Grace Therapeutics|AIFF: Accounting Value per Share|Net Assets per Share KLTO|NRSN - Net Assets per Single Share|Share Book Value Reviva Pharmaceuticals Holdings Inc. (RVPH)|Book Value per Share MTVA (MetaVia)|NeurAxis Inc - Book Value per Share|Net Assets per Single Share HSDT (Helius Medical Technologies Inc.)|NEUP - Net Assets per Share|Book Value per Share NERV (Minerva Neurosciences, Inc.)|ATHA (Athira Pharma Inc) - Book Value of One Share|Net Assets per Single Share Addex Therapeutics, Ltd. (ADXN)|Equity per Share Alzamend|Cyclerion Therapeutics - Book Value per Share|Net Asset Value per Share protagenic.com PTIX|Accounting Value per Share KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc - Book Value per Share|Net Assets per Single Share Avenue Therapeutics, Inc (ATXI)|BCLI: Accounting Value of a Share|Net Assets per Single Share CARA|CHRO (chromocell.com) - Net Asset Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc. ELYM|Share Book Value Intra-Cellular|Book Value per Share LBPH|Book Value per Share MRNS (Marinus Pharma)|Net Assets per Single Share NKGN|neurobopharma.com - Net Assets per Share|Net Assets per Single Share SAGE (Sage Therapeutics)|SNPX - Net Assets per Share|TRVN: Book Value per Share|Vigil Neuroscience, Inc. (VIGL) - Book Value per Share|Anew Medical - Book Value per Share|Book Value of One Share cerevel.com